Peritonitis in children undergoing continuous ambulatory peritoneal dialysis

Area of Science:

• Pediatric Nephrology
• Renal Replacement Therapy
• Dialysis Techniques

Background:

• Continuous ambulatory peritoneal dialysis (CAPD) is a vital treatment for pediatric end-stage renal disease.
• Peritonitis is a significant complication associated with peritoneal dialysis, particularly in children.
• Understanding peritonitis incidence and management in pediatric CAPD is crucial for optimizing patient outcomes.

Purpose of the Study:

• To determine the incidence of peritonitis in children undergoing CAPD.
• To analyze the treatment outcomes and complications of peritonitis in this pediatric cohort.
• To evaluate the safety and feasibility of continued CAPD use in children despite peritonitis risks.

Main Methods:

• A retrospective analysis of 29 children undergoing CAPD over a 20-month period.
• Calculation of peritonitis incidence rates per patient-month.
• Review of treatment strategies (ambulatory vs. inpatient) and associated hospitalization durations.
• Assessment of complications, including peritoneal catheter replacement.

Main Results:

• The incidence of peritonitis was one episode per 12.5 patient-months.
• 35% of peritonitis episodes were managed on an ambulatory basis; 65% required hospitalization.
• The annualized hospitalization rate was 3.8 days per patient.
• All patients recovered from peritonitis, with two cases necessitating peritoneal catheter replacement.

Conclusions:

• Peritonitis in pediatric CAPD patients is manageable and does not appear to be a prohibitive risk.
• The incidence and treatment outcomes suggest that CAPD remains a viable therapeutic option for children.
• The data support the continued utilization of CAPD in pediatric populations, emphasizing careful monitoring and management of peritonitis.